H001

N/A

Report date: 2025/12/18 10:56:10
NME

Base Information

Drug NameH001
Drug Alias NameH001H-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor modulators
TargetsAndrogen Receptor
Therapy Area/IndicationsShockVenous ThromboembolismProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHalda Therapeutics OpCo Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHalda Therapeutics OpCo IncLivzon Pharmaceutical Group IncLivzon(Group) Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsShockVenous ThromboembolismProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A